Dr. Hofmeister on Reolysin Combined With Carfilzomib for Multiple Myeloma
January 4th 2016Craig Hofmeister, MD, assistant professor of Internal Medicine, Division of Hematology, Department of Internal Medicine, Ohio State University, discusses a study that examined the efficacy of reolysin combined with carfilzomib in patients with relapsed multiple myeloma.
Read More